As of Dec 31, 2024, Incyte Corporation's fair value using the Ben Graham formula is ($20.0) per share. This is calculated using Ben Graham formula, where EPS is $0.2 and BVPS (Book Value Per Share) is $16.8. The current price of $72.1 suggests Incyte Corporation may be overvalued by this conservative metric.
Incyte Corporation earnings per share (EPS) for the twelve months ending Dec 31, 2024, was $0.2, a (52.7%) growth year-over-year.
Incyte Corporation's margin of safety is negative 127.7%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.